“…Essentially, these compounds serve as high-potency agonists for the human adenosine receptors and act as potential therapeutic agents for the treatment of Creutzfeldt-Jacob disease, Parkinson's disease, hypoxia, asthma, cancer, kidney disease and prion disease [3][4][5]. Due to their п-stacking ability, some pyridines are used in supramolecular chemistry [6][7][8]. Previously, 2,4,6-triarylpyridines have been prepared by the condensation of 1,5-diketones with formamide-formic acid [9], reaction of (aroylmethylene) isoquinolinium ylide with α, β-unsaturated ketones [10,11], and reaction of N-phenacylpyridinium salts with α, β-unsaturated ketones in the presence of ammonium acetate [12].…”